The design and analysis of stochastic cost-effectiveness studies for the evaluation of health care interventions

Andrew Briggs and Magnus Tambour ()
Additional contact information
Andrew Briggs: Health Economic Research Centre, Postal: Institute of Health Sciences, University of Oxford,
Magnus Tambour: Dept. of Economics, Stockholm School of Economics, Postal: Stockholm School of Economics, P.O. Box 6501, S-113 83 Stockholm, Sweden

No 234, SSE/EFI Working Paper Series in Economics and Finance from Stockholm School of Economics

Abstract: Many clinical trials are in progress which involve the collection of patient-level data on both the health outcome and resource use consequences of the health care interventions under evaluation. The overall aim of many such evaluations will be to undertake a cost-effectiveness analysis, which will often result in a cost-effectiveness ratio summarising the value for money of the intervention in question. In this paper, we explore the issues surrounding the design and analysis of such studies. At the design stage of an analysis, we propose an improved sample size formula for cost-effectiveness analysis that allows for covariance between cost and effect differences. This approach is based on the 'net benefits' approach to the analysis of uncertainty in cost-effectiveness analysis. At the analysis stage of an evaluation, we explore the differences and similarities of the 'net benefit' approach to analysing cost-effectiveness information and the traditional approach based on cost-effectiveness ratios. Despite the apparent differences, we show that the two approaches are exactly equivalent when it comes to estimating the probability that the intervention is cost-effective under alternative values of the ceiling cost-effectiveness ratio appropriate for decision-making purposes.

Keywords: Cost-effectiveness; Economic evaluation; Sample size (search for similar items in EconPapers)
JEL-codes: C12 C90 I10 (search for similar items in EconPapers)
Pages: 24 pages
Date: 1998-04-27
New Economics Papers: this item is included in nep-ecm, nep-exp, nep-hea and nep-pbe
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Published in Drug Information Journal, 2001, pages 1455-1468.

Downloads: (external link)
http://swopec.hhs.se/hastef/papers/hastef0234.pdf.zip (application/pdf)
http://swopec.hhs.se/hastef/papers/hastef0234.pdf (application/pdf)
http://swopec.hhs.se/hastef/papers/hastef0234.ps.zip (application/postscript)
http://swopec.hhs.se/hastef/papers/hastef0234.ps (application/postscript)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hhs:hastef:0234

Access Statistics for this paper

More papers in SSE/EFI Working Paper Series in Economics and Finance from Stockholm School of Economics The Economic Research Institute, Stockholm School of Economics, P.O. Box 6501, 113 83 Stockholm, Sweden. Contact information at EDIRC.
Bibliographic data for series maintained by Helena Lundin ().